Sean D. Carney's most recent trade in Beta Bionics Inc. was a trade of 16,965 Common Stock done . Disclosure was reported to the exchange on May 21, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beta Bionics Inc | Sean D. Carney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 16,965 | 32,209 | - | 0 | Common Stock | |
| Beta Bionics Inc | Sean D. Carney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2026 | 3,997 | 15,244 | - | 0 | Common Stock | |
| Beta Bionics Inc | Sean D. Carney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 11,247 | 11,247 | - | 0 | Common Stock | |
| Beta Bionics Inc | Sean D. Carney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 55,837 | 55,837 | - | - | Director Stock Option (right to buy) | |
| Beta Bionics Inc | Sean D. Carney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 30,456 | 30,456 | - | - | Director Stock Option (right to buy) |